A major advance in cancer study is emerging with the use of mini-antibodies to restore damaged p53. This crucial malignant inhibitor protein is frequently disabled in various kinds of cancer, leading uncontrolled body https://webnowmedia.com/story7437014/mini-antibodies-reactivate-p53-new-promising-pathway-for-malignant-management